UPC_CFI_477/2025 – Insulet v Eoflow
- Court
- Central Division Milan
- Date
- Outcome
- Granted
- Sector
- Other
- Decision Type
- PROCEDURAL
Expert Commentary
Legal costs / confidentiality Background Insulet filed cost proceedings after it had won PI proceedings in the Court of Appeal which reversed the decision of the CFI to refuse the PI (UPC_CoA_768/24). Insulet filed at the same time a request for confidentiality as to information regarding attorney’s fees and expenses both under R. 262A RoP and (the decision says) R. 262.4 RoP. Insulet claimed that the attorney’s fees and expenses were protected under attorney-client privilege and highly confidential. The JR 1. The JR gives a long exposé about R. 262A RoP, Art. 58 UPCA, Art. 9(2) of the Directive (EU) 2016/943 and Art. 39(2) TRIPS. 2. The JR states then “costs are not covered by confidentiality, unless they are specifically indicative of the company’s financial capacity, its commercial strategy or the importance of the patent as a corporate asset” but not “from the point of view of protecting the law firm”. 3. With respect to the latter, the JR refers to R. 262A RoP which only protects confidential information if contained in pleadings or the collection of evidence and use of evidence. 4. Art. 58 UPCA refers according to the JR to the confidential information of a party in the proceedings or a third party and thus to companies and the third party is certainly not the legal team involved in the proceedings. Decision of the JR Exhibit 2 and 3 are confidential and are only accessible to the representatives and employees of the law firm who need access for case management purposes and mr. Jesse Kim of EOFlow. Comment 1. The JR considers the invoices confidential “because it shows the interest of the patent owner defending his patent”. 2. What is not confidential is the breakdown of costs within the law firm and between individual employees, with an indication of the billable hours. 3. Then we have a mysterious remark by the JR that the amounts paid are every time higher than the invoiced amount. 4. It was argued by the law firm that all was considered “highly confidential” to such an extent that not even one person of the opposing party (bound to secrecy) could see it and that it was all protected under attorney-client privilege. 5. It was clear that no JR is going to accept this but it raises the question why was that law firm so nervous about anything becoming public? I have never had a situation in my practice in which the client every time paid more than the invoiced amount. 6. I applaud that the JR holds that under Art. 262A RoP the law firm cannot be considered as a third party and that invoices of law firms are not pleadings, different from what in the past has been held by other Divisions. 7. On the other hand the reasoning that the invoiced amount would divulge the importance of the patent for the company is strange. There may be all kind of other reasons why a company decides to litigate. Maybe the company does not consider the patent as very important and maybe the infringement is not very important but the company decides to enforce the patent in order to show the defendant and competitors that as soon as you come in the neighborhood of one of their patents, you have an expensive lawsuit on your hands. Quite frankly, I do not think that in practice patents are valued on the basis of what the patentee paid for a lawsuit! 8. As said before, I think it is much better to be completely transparent and if companies really think that the cheaper is the better in patent litigation then they will probably learn a very expensive lesson in the end. 9. Especially for companies without litigation experience (although I realize that they will probably not read this), I note the following: every lawyer who is a member of the bar in a UPC country and every European patent attorney without a law degree who followed a course to obtain a so called Art. 48.2 certificate (which course is, different from a drivers license test, always completed successfully) can act as a representative. 10. That does not make you automatically a top-class representative. If you want to litigate or if you are sued in the UPC (which is something very different from prosecution or opposition proceedings in the EPO), you better ask around who can best help you. The best source of information are not necessarily all these guides or conferences (where you find very often speakers who pay for speaking!) but general counsels of companies who have had the experience of litigating in the UPC. 11. Choosing only on the basis of price is not a good advice, but that is not a reason why there should not be transparency. __
Full Decision Text
1 Milan - Central Division - First Instance - central division UPC_CFI_477/2025 Procedural Order of the Court of First Instance of the Unified Patent Court delivered on 05/06/2025 Headnotes: In principle, the costs of the proceedings are not covered by confidentiality under Rule 262A RoP or by the attorney-client privilege unless they are specifically indicative of the company's financial capacity, its commercial strategy, or the importance of the patent as a corporate asset. Applying these principles, confidentiality as a general principle might also be granted to costs incurred by companies for legal services relating to litigation and patent protection, since this information might indicate the importance that companies attach to the patents they hold and the risk they are willing to take to protect them. APPLICANT/S Insulet Corporation (Applicant) - 100 Nagog Park - MA 01720 - Acton - US Represented by Marc Grunwald RESPONDENT/S EOFLOW Co., Ltd. (Respondent) - 302Ho, HUMAX VILLAGE, 216 - 13595 - Hwangsaeul-ro, Bundang-gu, Seongnam-si, Gyeonggi-do – KR Represented by Mirko Weinert PATENT AT ISSUE Patent no. Proprietor/s EP4201327 Insulet Corporation DECIDING JUDGE: judge rapporteur LANGUAGE OF PROCEEDINGS: English 2 SUBJECT-MATTER OF THE PROCEEDINGS: application for confidentiality Rule 262A RoP POINTS AT ISSUE On May 28, 2025, INSULET co. Ltd filed a request with this court for the payment of costs incurred as a result of the proceedings relating to the application for a preliminary injunction against the Korean company EOFLOW (UPC_CFI 380/24 and the following proceedings before the Court of Appeal UPC_CoA 768/24). INSULET also filed a request for confidentiality (262A) as to information regarding attorney’s fees and expenses incurred in connection with the application for PI. The request was accompanied by the filing of Exhibits 2a, and 4a in two versions, one complete and one partially redacted, following the provisions of article 262(4). Exhibit 3a appears to have been filed only in two versions too, the first one completely redacted (see below an example) and a second one partially redacted (see below). This version was indicated by the Applicant as partially redacted. 3 INSULET’s confidentiality request is based on: “The information designated as confidential (marked in grey as well as Exhibits PS 2a, 3a and 4a) is protected under the ‘attorney-client privilege’ pursuant to R. 287 RoP and is therefore inherently privileged. It pertains to the specifics of legal fees and is of a highly sensitive nature, as it contains information involving the hourly rates and certain communication between Applicant and its legal representatives. This information is not publicly known and is not accessible to any third party. Applicant and Applicant’s legal representatives have implemented appropriate measures to safeguard the confidentiality of this information. There exists a legitimate interest in maintaining its non-disclosure, and Applicant is entitled to a reasonable expectation of confidentiality in this regard”. The Club of confidentiality should be restricted according to INSULET’S submission only to a few legal representatives of EOFLOW, and thus not to the company itself, “Given the highly sensitive nature of the information at issue, the number of persons granted access must be strictly limited. For the purpose of these proceedings, there is no need to extend access to more than one individual on Respondent’s side, in addition to its UPC representatives”. EOFLOW submitted observations within the time limit indicated by the Court. EOFLOW requested the application to be dismissed, maintaining: • Information about the costs of litigation did not touch upon INSULET’s business and did not constitute a trade secret of the company but rather of its legal representatives, whose position was not considered by Rule 262A, • Some pieces of information were not even confidential, being related to translation costs, courier costs, and travel expenses, • EOFLOW’s interest in gaining access to the information was overriding INSULET’s confidentiality interests. • At least a natural person from each party must be involved in the club of confidentiality pursuant to the clear statement of Rule 262A so that any confidential information should not be restricted solely to legal representatives or to a designated employee of the counterparty. • Subordinately EOFLOW asked that the designated employee would be its CEO Jesse Kim. The application is admissible The Application contains the grounds upon which the applicant believes the information or evidence in question should be restricted in accordance with Article 58 of the Agreement. A redacted and an unredacted copy of the Exhibits were lodged with the application. The application is partially well-founded Rule 262A – Protection of Confidential Information - states: ‘1. Without prejudice to Article 60(1) of the Agreement and Rules 190.1, 194.5, 196.1, 197.4, 199.1, 207.7, 209.4, 315.2 and 365.2 a party may make an Application to the Court for an order that certain information contained in its pleadings or the collection and use of evidence in proceedings may be restricted or prohibited or that access to such information or evidence be restricted to specific persons’. Article 262 a RoP aims to preventing the disclosure of information of technical and commercial interest outside the perimeter of the necessary defence right, which is why, on the one hand, the disclosure of the documents in their full version outside the proceedings is prevented, and, on the other hand, access to the documents is always guaranteed to at least one person expressing the counterparty as well as to the defence team. Article 262A RoP also responds to reasons of efficiency, consistency, and procedural celerity because it allows the parties a more articulate defence by exposing confidential and privileged information while at the same time preventing the risk of its disclosure to the public. 4 Reference is made to UPCA Rule 58, Rule No. 262A, Directive (EU) 2016/943 on the protection of know-how and undisclosed business information (‘trade secrets’) and the solutions adopted by interpretation by the UPC in relation to the protection of confidential information. Indeed, the general rule outlined in Rule No. 262A, paragraph No. 6 of R.o.P.2 reproduces the wording used in the last paragraph of Article 9 (2) of Directive (EU) 2016/943 on the protection of know-how and undisclosed business information ('trade secrets). Before going into the merits of the claims made by INSULET, it should be recalled that the first legal mention of know-how or of “undisclosed information” is to be found in the Agreement on Trade-Related Aspects of Intellectual Property Rights (hereinafter referred to as TRIPS), which is Annex 1C to the Marrakesh Agreement signed on 15 April 1994 and which established the World Trade Organisation (WTO). Article 39(2) of TRIPS states that: ‘Natural and legal persons shall have the opportunity to prevent information lawfully under their control from being disclosed, acquired or used by others without their consent in a manner contrary to honest business practices, provided that such information': - are secret in the sense that the body of the information is not, as a body or in the precise configuration and assembly of its components, generally known or readily accessible to persons within the circles that normally deal with this type of information - have a commercial value because they are secret; - Have been subject to steps that were reasonable under the circumstances by the person lawfully in control of the information to keep it secret. These characteristics are then reproduced almost identically in Article 2 of Directive n° 943/2016. Thus, the main characteristics of protectable trade secrets are, according to this legal framework, secrecy, commercial value, and demonstrable investment to keep the information secret. It should be noted, however, that the concept of ‘trade secret’ in the context of the above- mentioned Directive is significantly broader than that of know-how, as it also includes commercial, accounting, and market information that cannot be translated into production processes. It must, therefore, be a piece of information which, individually or in combination, is such that it cannot be acquired by competitors within a reasonable time and at a reasonable cost, and whose knowledge by the competitor is either not possible, because it would require overcoming the company's defensive precautions, or is obtainable through effort or investment; secondly, the information must have an economic value, not in the sense that it has a market value, but in the sense that its use entails a competitive advantage on the part of the person implementing it, which makes it possible to maintain or increase market share; thirdly, the information must be subject, on the part of the persons to whose legitimate control it is subject, to specific measures that are reasonably adequate to maintain it secret. Applying these principles, confidentiality as a general principle might also be granted to costs incurred by companies for legal services relating to litigation and patent protection. This information might indicate the importance that companies attach to the patents they hold and the risk they are willing to take to protect them. This court, therefore, considers, on the other hand, that, in principle, the costs of the proceedings are not covered by confidentiality unless they are specifically indicative of the company's financial capacity, its commercial strategy, or the importance of the patent as a corporate asset. And thus, as correctly stated by the defendant's defense, protection cannot be recognized from the point of view of protecting the law firm about the disclosure of the costs it applies to patent litigation, but only from the point of view of the company, which is the sole beneficiary of the protection governed by Rule 262A RoP but not under the principle of attorney-client privilege. In fact, rule 262A refers to information ‘contained in its pleadings’ and evidence thereof and, therefore, to information identifiable as company secrets in the sense previously referred to. 5 Art. 58 UPCA refers to ‘confidential information of a party to the proceedings or of a third party’ and thus to companies, and the third party mentioned is undoubtedly not the legal team involved in the proceedings. In light of these considerations, the invoices issued by Law Firm Peterreins Schley and listed in Exhibit 2 can be protected by confidentiality because they show the patent owner's interest in defending it. However, this does not apply to the breakdown of costs within the law firm and between individual employees, with an indication of the billable hours referred to in Exhibit 4. With regard to Exhibit 3, a document has been submitted that appears to contain some of the invoices already filed as Exhibit no. 2, but which, however, shows an ‘invoice amount paid’ higher than the ‘original invoice amount’ for almost all invoices. It is not easy to understand the reason for filing this document, as it already contains data included in Exhibit 2. INSULET may clarify the relevance of this document during the phase relating to the determination of the costs of the proceedings; with regard to the confidentiality of this information, protection can be granted for the same reasons given for Exhibit No. 2. As to the concrete modalities and the identification of the ‘club’ of confidentiality, the general rule is the mandatory inclusion in the club of a natural person and the legal defence team. And this is pursuant to the letter of Rule No. 262A, paragraph No. 6 of the R.o.P. and Article 9 (2), last paragraph, of Directive (EU) 2016/943, cited above. The importance of this discipline has already been observed in application by other Local Courts of the UPC (i.e. the decision of the Local Court of Dusseldorf of 27 March 20241 UPC_CFI_355/2023) where the necessary examination of confidential information by a legal representative of defendant in order to ensure the fullness of the direct defence and cross- examination was emphasised. These specific rules specify that the number of persons referred to in the confidentiality club must not exceed the number necessary to ensure respect for the right of the parties to the judicial proceedings to an effective remedy and to a fair trial and must include at least one natural person for each party and the respective lawyers or other representatives of those parties to the proceedings. As regards the prohibition of access to individual natural persons, the Court observes, excluding the defendant or the natural person representing the company is only possible: I. on mutual agreement II. in case of waiver by the party concerned of the right of access by a natural person III. in antitrust behaviours In the present case, there is no agreement of the parties; the respondent has not waived the request for access by a natural person of its own and there is no interference with antitrust law. Therefore, INSULET’s request to limit confidentiality to law firms’ representatives is dismissed. The natural person representing EOFLOW can be identified as Jesse KIM, CEO of EOFLOW. The importance of the correct interpretation of the system of Section 262. (a) of the RoP in the light of the underlying rationale of the institute, highlighted above, suggests that the appeal should be admitted, also in the light of the need for a consistent interpretation, within the system, as expressly indicated by Preamble No. 8 of the RoP. 1 The court has to strike a balance between the adequate level of protection of said confidential information and the right of the claimant to have sufficient access to the information in order to exercise its right to be heard. In this context, R. 262A.6 RoP establishes with all desirable clarity as a ground rule of paramount importance that at least one natural person from each party and the respective lawyers or other representatives are to be granted access in order to ensure a fair trial. When deciding upon the level of restriction, again the circumstances of the case are to be taken into consideration. Whereas in some cases a restriction may be more important to safeguard the confidential information concerned, in other cases the right to full access to the files of a party trumps the interest of protection. 6 The appeal against this order is therefore admitted. The court issues the following ORDER Exhibits 2 and 3 lodged in No. ACT_25378/2025 in the unredacted version will be accessible only to the legal representatives of EOFLOW Ldt. including employees of the law firm who need access for case management purposes, and to Mr. JESSE KIM. The Registrar shall, as soon as practicable, take all necessary steps to give effect to this Order. Milan, 5 June 2025 judge rapporteur Andrea Postiglione INFORMATION ABOUT APPEAL Leave to appeal is granted. ORDER DETAILS Order no. ORD_25720/2025 in ACTION NUMBER: ACT_39640/2024 UPC number: UPC_CFI_477/2025 Action type: Application for provisional measures (RoP206) Related proceeding no. Application No.: 25415/2025 Application Type: APPLICATION_ROP262A
Key Holdings
- Invoices confidential if revealing company strategy/financial capacity.
- Law firms are not 'third parties' under Art. 58 UPCA for confidentiality.
- Breakdown of costs/hours not confidential.
- Access restricted to representatives and one named party individual.
Tags
- Attorney-Client Privilege
- Confidentiality
- Costs
- Security for Costs
Related Cases
- UPC_CFI_513/2024_May15_V2 – Maschio v Spiridonakis
- UPC CFI 628/2025 – Bodycap, National Center for Scientific Research - CNRS, University of Rennes v EPO
- UPC_CFI_382/2025_July31 – Novartis v Zentiva
- UPC_CFI_552/2025 – Gilead v Medical Sciences
- UPC CFI 513/2024 – Maschio Gaspardo S.p.A. v Spiridonakis Bros GP